Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wait for the RS
A bispecific antibody platform with melatonin (ILNS conjumab-a, antibodies conjugated to melatonin) could fit to oncology, IMO
http://cytoviaoncology.com/bispecific-antibodies/
http://www.oncologynurseadvisor.com/melanoma/melatonin-derivatives-exhibit-cytotoxic-activity-melanoma/article/736411/
Hold a bunch of several hundred k - buying more
Ask .085
MAZAs ILNS is ready to Rock!!
Yes indeed, expect something big soon
Check the sec filing in April ILNS and IMNP news in april
Well, OX1 would fit to their pipeline
RTO through Cerespir is more likely
http://gulffeed.com/0816760/global-mild-cognitive-impairment-therapeutic-market/
AD drug in phase 3 soon
Honig invested in MGTI, CDXC, and ... but whats about his ILNS stock?
Stakeholder invested to make money....
Its sold or a RTO
Thats not all of whats going on, wait and you will see...
Late stage entry point
As I said they prepared ILNS...
IMO ILNS will be used as a vehicle...
IMO it was sold or it's a RTO
Shire will spin off their Neurosciences by the end of 2017
Under .1
I invested after the analysation of facts
you will see...
Think about what happend in the past ....
They are recruting him to restructure, clean the books, wipe out debts and/or holders, sell to bigger co or for RTO, IMO.
The wind before the storm
Prepared for a ride...IMO
ILNS was cleaned up, think about it!
Yes, something is going on
IMO, MAZA wants to see $$$$ for his 10% in ILNS
http://www.immunepharma.com/who-we-are/management/
New Insight into Alzheimer’s Disease via Caspase 3-cleaved Tau: Pathogenic Role in Tau Oligomer Formation and Memory Deficits
Published date: July 05, 2017
https://www.omicsonline.org/open-access/new-insight-into-alzheimers-disease-via-caspase-3cleaved-taupathogenic-role-in-tau-oligomer-formation-and-memory-deficits-2161-0460-1000344.php?aid=92671